Informatics on Drug Repurposing for Breast Cancer
Hui Zhou,1,2,* Hongdou Liu,3,* Yan Yu,3 Xiao Yuan,3,4 Ling Xiao5 1Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China; 2Department of Lymphoma and Hematology, H...
Saved in:
Main Authors: | Zhou H (Author), Liu H (Author), Yu Y (Author), Yuan X (Author), Xiao L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of GPCR drugs for repurposing in breast cancer
by: Noor Mazin Abdulkareem, et al.
Published: (2022) -
Antifungal Drug Repurposing
by: Jong H. Kim, et al.
Published: (2020) -
Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2
by: Irving Balbuena-Rebolledo, et al.
Published: (2021) -
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020) -
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
by: Mengjie Rui, et al.
Published: (2022)